Different subgroups were assessed for risk scores based on age, gender, tumor location, survival status, T-stage, tumor stage, EGFR mutation status and KRAS mutation status, wherein all the subgroups had significant differences except the tumor location and EGFR mutation status subgroups. Here, EGFR is linked to neoplasm.